NCT06095440View on ClinicalTrials.gov

A Retrospective Analysis of Outcomes in Patients with Hepatorenal Syndrome At Methodist Dallas Medical Center

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

May 13, 2023

Primary Completion Date

May 13, 2025

Study Completion Date

May 13, 2025

Conditions
Hepatorenal Syndrome
Interventions
OTHER

Hepatorenal Syndrome outcome in Patients at Methodist Health systems

1.2.1. To perform a retrospective analysis of patients with HRS with the aim of comparing various treatment modalities such as vasoconstrictors, albumin, CRRT, Molecular Adsorbent Recirculating System (MARS), and TIPS.

Trial Locations (1)

75203

RECRUITING

Liver Institute of Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER